Previous 10 | Next 10 |
WALTHAM, Mass., April 18, 2023 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN) today announced that the Company will report its first quarter 2023 financial results on Tuesday, May 2, 2023. The Company will issue a press release before the market opens and will host a conference call at 8:...
2023-04-13 00:30:00 ET Summary In the Russell 1,000, 33 names are up more than 1,000% since April 12th, 2013. Over the same 10-year period, the S&P 500 tracking ETF is up 211%. The obvious next question is: which stocks will be ten baggers over the next ten years? ...
2023-04-12 11:48:39 ET Repligen ( NASDAQ: RGEN ) stock rose ~4% on Wednesday after the company said it was acquiring FlexBiosys in a cash and equity transaction. The company said it executed an equity purchase agreement with FlexBiosys, TSAP Holdings (NJ Seller), Gay...
2023-04-04 23:00:00 ET Summary LRT Capital is a fundamental investment hedge fund. Our sole aim in crafting our investment program is to maximize long-term investment returns. March was a very good month for our strategy. Our core holdings were close to flat overall while our hedg...
2023-04-03 05:21:52 ET Goldman Sachs is sticking with its S&P 500 ( SP500 ) ( NYSEARCA: SPY ) target of little change by year end as valuations and earnings face headwinds near term, its equity team said. "Our Long Duration basket has outperformed the Short Duration bask...
2023-03-12 10:23:23 ET Summary Repligen's exclusive partnerships with companies such as DRS Daylight Solutions and Purolite give it a competitive edge in the industry. The company's diverse product line includes pre-packed columns, alternating tangential flow, tangential flow filt...
Start Time: 08:30 End Time: 09:37 Repligen Corporation (RGEN) Q4 2022 Earnings Conference Call February 22, 2023, 08:30 AM ET Company Participants Tony Hunt - President and CEO Jon Snodgres - CFO Sondra Newman - Head, IR Conference Call Participants ...
Repligen press release ( NASDAQ: RGEN ): Q4 Non-GAAP EPS of $0.68 beats by $0.10 . Revenue of $186.76M (+0.1% Y/Y) beats by $2.35M . YEAR 2023 GUIDANCE: Total reported revenue is expected to be in the range of $760-$800 million vs. $800.24M consensus. This guid...
Fourth quarter revenue of $186.8 million represents year-over-year organic growth of 4% and 5% growth at constant currency Full year revenue of $801.5 million represents year-over-year organic growth of 22% and 25% growth at constant currency Base business organic growth was 35%...
Repligen ( NASDAQ: RGEN ) is scheduled to announce Q4 earnings results on Wednesday, February 22nd, before market open. The consensus EPS Estimate is $0.58 (-28.4% Y/Y) and the consensus Revenue Estimate is $184.41M (-1.1% Y/Y). Over the last 2 years, RGEN has beaten EPS est...
News, Short Squeeze, Breakout and More Instantly...
WALTHAM, Mass., July 16, 2024 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN) today announced that the Company will report its second quarter 2024 financial results on Tuesday, July 30, 2024. The Company will issue a press release before the market opens and will host a conference call at ...
2024-07-04 04:54:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-06-21 14:00:08 ET Daniel Arias from Stifel Nicolaus issued a price target of $207.00 for RGEN on 2024-06-21 12:12:00. The adjusted price target was set to $207.00. At the time of the announcement, RGEN was trading at $123.16. The overall price target consensus is at...